CD4 and neoplasm: As expected, tumor-bearing mice showed significant decrease in blood and splenic CD4+ and CD8+ T cells (Figures 4G and S5B), increased splenic macrophages (Figure S5C), as well as increased g-MDSC/neutrophils populations in the blood (Figure 4H), independent of treatment with FK506.